François Guilhot, Brian Druker, Richard A. Larson, Insa Gathmann, Charlene So, Roger Waltzman, Stephen G. O’Brien. High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial. Haematologica 2009;94(12):1669-1675; https://doi.org/10.3324/haematol.2009.010629.